Unverified50% confidenceFactExact time
Drug development processes are highly standardized and involve large amounts of sensitive data, so AI platforms need to meet strict compliance requirements such as GxP and HIPAA.
1
Sources
50%
Confidence
Long-term
Relevance
10/21/2026
First Seen
Sources
Related Entities
Related Claims
Unverified美国FDA在2021年发布的《AI/ML软件行动计划》中提出'预定变更控制计划'（Predetermined Change Control Plan）框架，要求AI辅助医疗决策工具提供完整证据链68% similarUnverifiedIntroducing an AI gateway control layer is worth evaluating when dealing with multiple models, multiple providers, cost sensitivity, or compliance requirements.68% similarUnverifiedFinancial institutions have extremely high requirements for the data security, compliance, and auditability of AI tools.66% similarUnverifiedThe FDA chose to build its AI-ready data infrastructure on the Databricks for Government platform.66% similarVerifiedThe FDA has a clear regulatory framework for AI-assisted medical decision-making tools, classifying them as Software as a Medical Device (SaMD).66% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1078760API
curl https://kongchang.com/api/v1/knowledge/claims/1078760MCP
get_claim(id=1078760)